{"symbol": "MNLO", "companyName": "Menlo Therapeutics Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.menlotherapeutics.com", "description": "Menlo Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.", "CEO": "Steven L. Basta", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}